PRELIMINARY RESULTS OF DARATUMUMAB, CYCLOPHOSPHAMIDE, THALIDOMIDE AND DEXAMETHASONE: A QUADRUPLET INTENSIED TREATMENT FOR NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) TRANSPLANT ELIGIBLE (TE) PATIENTS

Bibliographic Details
Main Authors:	E.Q. Crusoé, M.A. Salvino, S.Q. Silva, H.H.M. Santos, A.S. Santos, A.M. Almeida, L.O. Vieira, C.A. Fonseca, L.F. Lucas, J.S. Leal, M.M. Santos, J.A. Santos, E. Adorno, V.T.M. Hungria, M.G.B. Arruda
Format:	Article
Language:	English
Published:	Elsevier 2020-11-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137920307410

Internet